Effects of nitric oxide modulators on cardiovascular risk factors in mild hyperhomocysteinaemic rat model

Basic and Clinical Pharmacology and Toxicology

Volumn 103, Issue 1, 2008, Pages 25-30

  Sharma, Meenakshi ^a   Rai, Santosh Kr ^a   Tiwari, Rakesh Kr ^a   Tiwari, Manisha ^a   Chandra, Ramesh ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CAVEOLIN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; METHIONINE; N(G) NITROARGININE; NITRATE; NITRITE; NITROPRUSSIDE SODIUM; PEPTIDOLEUKOTRIENE; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; RESISTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HYPERHOMOCYSTEINEMIA; LIPID ANALYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RISK FACTOR;

ACYL COENZYME A; ANIMALS; AORTA, THORACIC; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAVEOLIN 2; DISEASE MODELS, ANIMAL; HYPERHOMOCYSTEINEMIA; LEUKOTRIENES; LIPID METABOLISM; LIVER; MALE; METHIONINE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROARGININE; NITROPRUSSIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P2; RESISTIN; RISK FACTORS;

ANIMALIA; RATTUS;

EID: 45749127743     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2008.00215.x     Document Type: Article

References (31)

1. Tyagi N, Moshal KS, Tyagi SC. Mechanisms of homocysteine induced oxidative stress. Am J Physiol Heart Circ Physiol 2005 289 : 2649 56.
2. Lang D, Kredan MB, Moat SJ, Hussain SA, Powell CA, Bellamy MF et al. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler Thromb Vasc Biol 2000 20 : 422 7.
3. Laufs U. Beyond lipid lowering: effects of statins on endothelial nitric oxide. Eur J Clin Pharmacol 2003 58 : 719 31.
4. Rekka EA, Chrysselis MC. Nitric oxide in atherosclerosis. Mini Rev Med Chem 2002 2 : 585 93.
5. Upchurch GR, Welch G, Fabian A, Freedman J, Johnson J, Keaney J et al. Stimulation of endothelial nitric oxide production by homocysteine. Atherosclerosis 1997 132 : 177 85.
6. De Groote MA, Testerman T, Xu Y, Stauffer G, Fang FC. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 1996 272 : 414 7.
7. Sharma M, Rai S K, Tiwari M, Chandra R. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Eur J Pharmacol 2007 574 : 49 60.
8. Zhang X, Li H, Jin H, Ebin Z, Brodsky S, Goligorsky SM. Effects of homocysteine on endothelial nitric oxide production. Am J Physiol Renal Physiol 2000 279 : F671 8.
9. Jurevics H., Hostettler J, Barrett C, Morell P, Toews AD. Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase. J Lipid Res 2000 41 : 1048 53.
10. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959 37 : 911 7.
11. Zlatkis A, Zak B, Boyle AJ. A new method for the direct determination of serum cholesterol. J Lab Clin Invest 1953 41 : 486 92.
12. Vanhandel E, Zilversmit DB. Micromethod for the direct determination of serum triglycerides. J Lab Clin Invest 1957 50 : 152 7.
13. Venugopala RA, Ramakrishanan S. Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH). Clin Chem 1975 21 : 1523 5.
14. Ahotupa M, Ruutu M, Mantyla E. Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins. Clin Chem 1996 29 : 139 44.
15. Grove TH. Effect of reagent pH on determination of high density lipoprotein cholesterol by precipitation with sodium phosphotungustate- magnesium. Clin Chem 1979 25 : 560 4.
16. Hortelano S, Dewez B, Genaro AM, Daiz-Guerra MJ, Bosca L. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology 1995 21 : 776 86.
17. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S, Cosic V. Methods for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001 54 : 356 61.
18. Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromotagraphy 1991 565 : 441 6.
19. Baba MI, Kaul D, Grover A. Importance of blood cellular genomic profile in coronary heart diseases, J Biomed Sci 2006 13 : 17 26.
20. Stamler JS, Osborn JA, Jaraji O, Rabbani LE, Mullins M, Singel D et al. Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993 91 : 308 18.
21. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR et al. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest 1996 98 : 24 9.
22. Siegel P, Maraca PP, Green JR. Sodium nitroprusside in the surgical treatment of cerebral aneurysms and arteriovenous malformations. Br J Anaesth 1971 43 : 790 5.
23. Duan XW, You YLG, Su XG, Qu HX, Joyce DC, Jiang YM. Influence of the nitric oxide donor, sodium nitroprusside, on lipid peroxidation and anti-oxidant activity in pericarp tissue of longan fruit. J Hortic Sci Biotechnol 2007 82 : 467 73.
24. Racotta R, Soto-Mora LM, Piñón M, Quevedo L. Some particularities of sodium nitroprusside stimulatory effects on food intake. Life Sci 2001 69 : 659 68.
25. ω nitroarginine, by less synthesis of bile acids. Biosci Biotechnol Biochem 1998 62 : 773 7.
26. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM. The hormone resistin links obesity to diabetes. Nature 2001 409 : 307 12.
27. Han KH, Hong KH, Park JH, Ko J, Kang DH, Choi KJ et al. C-Reactive protein promotes monocyte chemoattractant protein-1-mediated chemotaxis through up-regulating CC chemokine receptor 2 expression in human monocytes. Circulation 2004 109 : 2566 71.
28. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 2000 102 : 1000 6.
29. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002 106 : 1439 41.
30. Helgadottir A, Manolescu A, Thorleifsson G. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004 36 : 233 9.
31. Sbaa E, Frérart F, Feron O. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc Med 2005 15 : 157 62.